Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression

被引:39
作者
Capece, Maxx [1 ]
Huang, Zhonghui [2 ]
Dave, Rajesh [2 ]
机构
[1] AbbVie Inc, Res & Dev, Drug Prod Dev, N Chicago, IL 60064 USA
[2] New Jersey Inst Technol, Dept Chem Pharmaceut & Biol Engn, Newark, NJ 07102 USA
关键词
direct compression; dry coating; tableting; formulation development; tabletability; PHARMACEUTICAL POWDERS; TENSILE-STRENGTH; FLOW PROPERTIES; PARTICLE-SIZE; TRUE DENSITY; MICROCRYSTALLINE CELLULOSE; COMPACTION BEHAVIOR; PERCOLATION THEORY; BULK-DENSITY; SILICA;
D O I
10.1016/j.xphs.2017.02.033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In a recent study, it was demonstrated that improving flow of a model poorly flowing and poorly compactable drug substance, acetaminophen, via dry coating while using fine excipients, may promote direct compression. To validate this novel strategy, particularly for high drug-loading formulations, this study investigates the effect of microcrystalline cellulose (MCC) particle size and dry coating on powder tabletability and flowability. It was determined that blends containing fine-sized MCC (20 mm) resulted in the highest tablet tensile strength and best tabletability because it provides higher interparticle contact area compared with coarse-sized MCC. Although tabletability can be improved using fine MCC, flowability is poor but can be improved through dry coating, a process that coats glidants (nano-sized silica) onto particle surfaces. To retain the tabletability, which was adversely affected because of the presence of glidant in the blend, while simultaneously enhancing flowability via dry coating, separately blending the drug substance with glidant is shown to be the best method of processing. The combined use of fine excipients and selective dry coating offers a novel and advantageous formulation strategy in comparison with the conventional use of coarse excipients, such as Avicel PH 102, that have been designed and marketed for direct compression. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1608 / 1617
页数:10
相关论文
共 36 条
[1]   Profoundly Improving Flow Properties of a Cohesive Cellulose Powder by Surface Coating with Nano-silica Through Comilling [J].
Chattoraj, Sayantan ;
Shi, Limin ;
Sun, Changquan Calvin .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (11) :4943-4952
[2]   Tablet Tensile Strength: An Adhesion Science Perspective [J].
Etzler, Frank M. ;
Bramante, Tommasina ;
Deanne, Richard ;
Sienkiewicz, Svetlana ;
Chen, F. J. .
JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY, 2011, 25 (4-5) :501-519
[3]   DETERMINATION OF TABLET STRENGTH BY DIAMETRAL-COMPRESSION TEST [J].
FELL, JT ;
NEWTON, JM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (05) :688-&
[4]   Multi-faceted characterization of pharmaceutical powders to discern the influence of surface modification [J].
Ghoroi, Chinmay ;
Gurumurthy, Lakxmi ;
McDaniel, D. J. ;
Jallo, Laila J. ;
Dave, Rajesh N. .
POWDER TECHNOLOGY, 2013, 236 :63-74
[5]   Flow and bulk density enhancements of pharmaceutical powders using a conical screen mill: A continuous dry coating device [J].
Huang, Zhonghui ;
Scicolone, James V. ;
Gurumuthy, Lakxmi ;
Dave, Rajesh N. .
CHEMICAL ENGINEERING SCIENCE, 2015, 125 :209-224
[6]   Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating [J].
Huang, Zhonghui ;
Scicolone, James V. ;
Han, Xi ;
Dave, Rajesh N. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 478 (02) :447-455
[7]   Improvement of flow and bulk density of pharmaceutical powders using surface modification [J].
Jallo, Laila J. ;
Ghoroi, Chinmay ;
Gurumurthy, Lakxmi ;
Patel, Utsav ;
Dave, Rajesh N. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 423 (02) :213-225
[8]  
Jenike A.W., 1964, STORAGE FLOW SOLIDS
[9]  
Jivraj Mira, 2000, Pharmaceutical Science and Technology Today, V3, P58, DOI 10.1016/S1461-5347(99)00237-0
[10]   A new theoretical approach to tablet strength of a binary mixture consisting of a well and a poorly compactable substance [J].
Kuentz, M ;
Leuenberger, H .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (02) :151-159